Shattuck Labs (NASDAQ: STTK) revenue
Shattuck Labs reported revenue of $1.0m for fiscal 2025, 82.5% less than in fiscal 2024 ($5.7m). Since fiscal 2019 its revenue has fallen by 89.9%, an average decline of 31.7% a year.
Shattuck Labs's best year of the last 7 was fiscal 2021. The biggest drop was in fiscal 2022, −97.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $1.0m | −82.5% | −$51.5m | −5,150.8% |
| 2024 | $5.7m | +245.3% | −$80.6m | −1,408.3% |
| 2023 | $1.7m | +154.1% | −$92.0m | −5,549.6% |
| 2022 | $0.7m | −97.8% | −$103.3m | −15,848.0% |
| 2021 | $30.0m | +202.2% | −$45.3m | −150.8% |
| 2020 | $9.9m | +0.5% | −$36.9m | −371.8% |
| 2019 | $9.9m | — | −$25.1m | −253.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Shattuck Labs revenue compared with its sector
By revenue for its latest fiscal year, Shattuck Labs ranks 396th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Shattuck Labs, −82.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 394th | Celldex Therapeutics | $1.5m | −78.0% |
| 395th | Inhibrx Biosciences | $1.3m | 550.0% |
| 396th | Shattuck Labs | $1.0m | −82.5% |
| 397th | ProKidney | $0.9m | 1,075.0% |
| 398th | Pulse Biosciences | $0.4m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Shattuck Labs
- How much revenue did Shattuck Labs make in fiscal 2025?
- Shattuck Labs reported revenue of $1.0m for fiscal 2025, compared with $5.7m in fiscal 2024.
- How much has the revenue of Shattuck Labs fallen?
- Between fiscal 2019 and fiscal 2025 it went from $9.9m to $1.0m: 89.9% less, an average decline of 31.7% a year.
- What was the best year for revenue at Shattuck Labs?
- Of its last 7 fiscal years, fiscal 2021, with $30.0m.
- Where does Shattuck Labs rank in its sector by revenue?
- It ranks 396th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Shattuck Labs come from?
- From the annual report (Form 10-K) that Shattuck Labs files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Shattuck Labs files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Shattuck Labs: the Shattuck Labs page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.